Revumenib Monotherapy in Patients with Relapsed/Refractory KMT2Ar Acute Leukemia: Topline Ef cacy and Safety Results from the Pivotal Augment-101 Phase 2 StudyIbrahim Aldoss,Ghayas C. Issa,Michael Thirman,John DiPersio,Martha Arellano,James S. Blachly,Gabriel N. Mannis,Alexander Perl,David S. Dickens,Christine M. McMahon,Elie Traer,C. Michel Zwaan,Carolyn Grove,Richard Stone,Paul J. Shami, Ioannis Mantzaris,Matthew Greenwood,Neerav Shukla,Branko Cuglievan, Yu Gu,Rebecca G. Bagley,Kate Madigan, Soujanya Sunkaraneni,Huy Van Nguyen, Nicole McNeer,Eytan M. SteinBlood（2023）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
